Atlas Trials

Phase 2 Study of Darbepoetin Alfa Extended Dosing

Clinical trial NCT00527215 · COMPLETED

Trial details

NCT number
NCT00527215
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pre-Dialysis
Start date
2002-03-01
Primary completion
2003-10-01
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.